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1. Introduction 
Fatty acids are widely distributed in nature. In addition to being found in plants and seeds, 
these organic compounds are present in other organisms, from unicellular protists to 
mammals, including humans. The anabolic and catabolic pathways of fatty acids have been 
identified. They have a well-known function as energy sources in metabolic processes and 
constitute a fundamental part of cellular membrane structures. Long-chain fatty acids also 
play a role in inflammatory process.  Fatty acids exert their actions by modifying the fluidity 
of membranes, exerting marked actions on membrane ionic channels, and leading to a 
reduction in the excitability of cardiac myocytes, thus prompting interest in the study of 
fatty acids as protectors of cardiac function. Fatty acids exert similar actions on membrane 
neurons and the modulation of neurotransmission. The role of fatty acids in several 
psychiatric and neurologic conditions is a topic of current research. Fatty acid deficiency 
appears to be related to alterations in development, but the results from supplementary diet 
studies are far from conclusive. Interestingly, fatty acids are present in amniotic fluid, 
colostrum, and maternal milk in at least two mammalian species (i.e., pigs and humans) and 
according to both anecdotal and experimental reports appear to produce anxiolytic effects. 
Additionally, fatty acids exert effects when applied by the olfactory route. Odorant carrier 
proteins to olfactory receptors are present in maternal fluids and nasal mucosa epithelia. In 
newborns, fatty acids may also act as olfactory cues for feeding source seeking after 
exposure during prenatal life, which may constitute an additional function. 
2. Overview  
Lipids are organic compounds that are insoluble in water but soluble in nonpolar solvents, 
such as ether and chloroform. Some of these lipids naturally occur in the marine food chain. 
From an evolutionary ecological perspective, their presence in dinoflagelates, teleosts, 
amphibians, reptiles, birds, mammalians, and humans is important (Crawford et al., 2009). 
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In mammals, the highest lipid concentrations occur in adipose tissue, followed by the 
central nervous system (Carrié et al., 2000). However, lipids are present in all cell types, 
where they contribute to cell structure and energy storage and participate in many 
biological processes, such as gene transcription, the regulation of metabolic pathways, and 
other physiological processes (Gurr et al., 2002). 
The biological functions of lipids are as diverse as their chemistry. Fats and oils are the main 
forms of energy storage in many organisms, and phospholipids and sterols are the major 
structural elements of biological membranes. Other lipids, although present in relatively 
small amounts, play a crucial role in the composition of enzymatic cofactors, electron 
carriers, light pigments, membrane protein folding, digestive tract emulsifiers, hormones, 
and intracellular messengers (Nelson & Cox, 2005). Fatty acids are the main component of 
phospholipids, triglycerides, and cholesterol esters (Agostoni & Bruzzese, 1992). 
2.1 Definition and classification 
Fatty acids are aliphatic carboxylic acids composed of four to 36 carbon chains and a 
variable degree of unsaturation, ending in a carboxyl group (Berg et al., 2003; Nelson & Cox, 
2005). The moiety of carbon chains can be short (2-4 carbons), medium (6-12 carbons), long 
(14-18 carbons), and very long (derived from 18 carbon molecules; Agostoni & Bruzzese, 
1992). The hydrocarbon chain can be saturated or may have one or more double unsaturated 
bonds (Bézard et al., 1994). Based on the number of unstaurations, the hydrocarbon chain 
may constitute monounsaturated fatty acids (MUFA) or polyunsaturated fatty acids (PUFA; 
Agostoni & Bruzzese, 1992; Bézard et al., 1994). The classification of PUFA is based on the 
location of the last double-bond near the methyl end, yielding the typical location n-3 or n-6. 
However, mammals cannot introduce double-bonds between C-9 and the methyl end of 
fatty acids; thus, mammals are not able to synthesize n-3 or n-6 PUFA or convert n-3 PUFAs 
into n-6 PUFAs or vice versa (Bézard et al., 1994; Colin et al., 2003; Dobryniewski et al., 
2007). Instead, n-3 and n-6 PUFA are derived from other fatty acids that act as precursors 
(Stulnig, 2003). n-3 and n-6 PUFA can be synthesized from the precursors linoleic acid (18:2) 
and -linolenic acid (18:3), which in turn may be synthesized from shorter-chain fatty acids, 
such as palmitic acid (C16:0; Cunnane et al., 1995). Similarly, saturated fatty acids (SFA) and 
MUFA can be synthesized from acetate precursors (e.g., carbohydrates, glycogenic amino 
acids) and PUFA (Brenna et al., 2009). 
2.2 General properties 
Fatty acids are esters in natural fats and oils but also exist in non-esterified forms, such as 
free fatty acids, that circulate in the blood of vertebrates via noncovalent bonds with the 
carrier protein serum albumin. Typically, the most abundant fatty acids have carbon chains 
from 14 to 24 atoms, although the most abundant fatty acids contain 16 to 18 atoms. In 
nature, the most abundant are unsaturated fatty acids, followed by saturated, with double-
bonds and a cis configuration (Berg et al., 2003; Nelson & Cox, 2005). The cis configuration 
can be converted to the trans form by catalytic heating. Saturated fatty acids are very stable, 
whereas unsaturated acids are susceptible to oxidation (i.e., the more double-bonds, the 
higher susceptibility to oxidation; Gurr et al., 2002). 
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2.3 Physical and chemical properties 
The physical properties of fatty acids are related to the length of their carbon chain and 
unsaturation. The nonpolar characteristics of the hydrocarbon chain explain the poor 
solubility of fatty acids in water. The polar carboxylic acid group (ionized at neutral pH) 
explains the poor solubility of short-chain fatty acids in water (Berg et al., 2003; Nelson & 
Cox, 2005). Likewise, longer chains have a higher melting point. Unsaturated fatty acids 
have a melting point that is lower than that of saturated fatty acids of the same length (Berg 
et al., 2003; Nelson & Cox, 2005). 
2.4 Anabolic processes 
The biotransformation process of fatty acids has been summarized by Nelson and Cox 
(2005). The synthesis of fatty acids may occur by de novo synthesis or modification of the 
carbon chain (Gurr et al., 2002). In de novo synthesis, fatty acids are synthesized from 
pyruvate, the final product of glycolysis, with the participation of a three-carbon 
intermediary and malonyl-CoA, an irreversible catalytic product of acetyl-CoA (Gurr et al., 
2002). 
The assembly of the carbon chains of fatty acids occurs through a four-step sequence. A 
saturated acyl group is the substrate for subsequent condensation with an activated malonyl 
group. With each step of the cycle, the acyl chain is extended by two carbons. The cycle is 
completed with the formation of a chain of 16 carbons (i.e., palmitic acid [C16:0], an SFA). 
Carbons C-16 and C-15 from palmitic acid are derived from the carboxyl and methyl 
carbons, respectively, of an acetyl-CoA. Other carbons are derived from acetyl-CoA via 
malonyl-CoA. NADPH acts as a reducing agent, and the two SH groups that are bound to 
the enzyme are the active group. All reactions in the synthesis are catalyzed by a 
multienzymatic complex, fatty acid synthase. 
Palmitic acid is the terminal product in fatty acid synthesis in animal cells and is the 
precursor SFA and MUFA through elongation of the carbon chain. Palmitic acid (16:0) can 
be elongated to form stearate (18:0) or a longer carbon chain through the addition of acetyl 
groups with the participation of elongase enzymes. The process occurs via two elongation 
systems located in the mitochondria and smooth endoplasmic reticulum from the liver, 
brain, and some other tissues (Gurr et al., 2002). 
One of the most important functions of elongation is the conversion of essential fatty acids 
into PUFA (Gurr et al., 2002). However, these fatty acids cannot be synthesized by 
mammalian cells and must be obtained from the diet as linoleic acid (18:2) and -linolenic 
acid (18:3) to be transformed into PUFA, such as dihomo--linolenic acid (18:3), arachidonic 
acid (20:4), eicosapentaenoic acid (20:5), and docosahexaenoic acid (DHA; 22:6; Haggarty, 
2002). 
A second mechanism for the synthesis of fatty acids is desaturation (Gurr et al., 2002). 
Palmitic acid and stearic acid serve as the precursors of two of the most common MUFA in 
animal tissues (i.e., palmitoleic acid [16:1] and oleic acid [18:1]), which have a cis double-
bond between C-9 and C-10. The double-bond is introduced into the fatty acid chain by an 
oxidative reaction with the participation of O2, NADH, and three proteins: cytochrome b5, a 
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flavoprotein (cytochrome b5 reductase), and the enzyme acyl-CoA desaturase, which 
catalyzes the reaction and acts at specific positions in the fatty acid carbon chain (Sprecher et 
al., 1995). Mammals have two types of desaturases: stearoyl-CoA desaturase (which 
catalyzes the synthesis of MUFA) and A5D/A6D desaturases (which participate in the 
biosynthesis of PUFA; Sampath & Ntambi, 2005). 
2.5 Catabolic processes 
┚-oxidation is the conversion of fatty acids to acetyl-CoA and is the main source of energy 
for most organisms. Its name derives from the position of the carbon attacked in the acyl 
chain, and the process occurs in the mitochondria and peroxisomes (Gurr et al., 2002). ┚-
oxidation occurs in three stages. In the first stage, the fatty acids lose two carbon units by 
oxidative removal, starting from the carboxyl group and ending in the acyl chain. For 
example, palmitic acid undergoes seven steps in the oxidative sequence and at each step 
loses two carbons as acetyl-CoA. At the end of seventh cycle, the C-15 and C-16 palmitic 
acid carbons still remain as acetyl-CoA. The final result is the conversion of the 16-carbon 
chain of palmitic acid into eight two-carbon acetyl groups in acetyl-CoA molecules. The 
formation of acetyl-CoA requires the removal of four hydrogen atoms (two pairs of 
electrons and four H+) in the middle of the acyl group by dehydrogenases. 
In the second stage of oxidation, the acetyl groups of acetyl-CoA are oxidized in the 
mitochondrial matrix into CO2 in the citric acid cycle. Thus acetyl-CoA derived from fatty 
acids enters the final stage of the oxidation of acetyl-CoA derived from glucose via 
glycolysis and pyruvate oxidation. The first two stages of oxidation produce NADH and 
FADH2, which in the third stage donate electrons to the respiratory chain, and electrons 
pass to oxygen, resulting in the phosphorylation of ADP to ATP; thus, the result of the ┚-
oxidation of fatty acids is ATP. 
2.6 Physiological role 
Fatty acids are involved in energetic, metabolic, and structural processes. Short-chain fatty 
acids act as growth factors. Long saturated chains are a source of energy, and long-chain 
unsaturated chains participate in fundamental metabolic processes (Agostoni & Bruzzese, 
1992), such as the synthesis of eicosanoids, which are closely related to inflammatory 
processes (Mesa-García et al., 2006; Zamaria, 2004), the modulation of enzymatic activity, 
the activation of nuclear transcription factors, and the formation of free radicals in response 
to oxidative stress (Zamaria, 2004). 
Very long-chain molecules constitute biological membranes and participate in development 
(Agostoni & Bruzzese, 1992). n-3 PUFA (linolenic acid) and n-6 PUFA (linoleic acid; Bézard 
et al., 1994; Colin et al., 2003; Sardesai, 1992; Sinclair, 1984) are structural components of all 
tissues and indispensable for the synthesis of the cell membrane (Uauy et al., 2000). 
2.7 Mechanism of action on excitable tissues 
Fatty acids accumulate in membrane phospholipids near the ion channel, which alters the 
tension of the membrane, causes conformational changes in the ion channel, and 
consequently alters its conductance (Leaf et al., 2002). Two forms of Na+/K+-ATPase 
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catalytic subunits are present in the nervous system. The  form is present in astrocytes, 
glial cells, and other tissues and is seemingly related to K+ clearance. The + subunit is 
present in neuronal tissue, possesses high affinity for cardiac glycosides, is stimulated by 
biogenic amines, and participates in Na+ and K+ transport. In addition to the well known 
role of the Na+/K+ pump in resting membrane potential, it also participates in the 
differentiation of nerve cells during neurulation (Stahl, 1986). The modulation of membrane 
protein function by molecules that possess both hydrophilic and hydrophobic ends has been 
ascribed to changes in bilayer fluidity and alterations in bilayer stiffness. For example, N-
type calcium channels may be modulated by a decrease in bilayer stiffness (Lundbaek et al., 
1996). 
Because of the reputation of PUFA as cardiac protectors, many studies have explored the 
action of fatty acids on cardiac myocytes. In these cells, n-3 and n-6 PUFA (DHA, -linolenic 
acid, arachidonic acid, and linoleic acid) but not trans MUFA or SFA reduce Na+ currents 
(Xiao et al., 1995). Free PUFA modulate voltage-sensitive Na+ channels through the 
inhibition of agonist binding to the Na+ channel protein in a dose-dependent, saturable, 
reversible, and allosteric manner (Kang & Leaf, 1996) but do not upregulate cardiac Na+ 
channel expression in the long-term (Kang et al., 1997). Although PUFA may produce 
supraventricular and ventricular arrhythmias, its anti-arrhythmic properties are attributable 
to inhibition of Na+ voltage-dependent currents, leading to hyperpolarization and reducing 
the availability and release of Ca2+ and sharing some actions with lidocaine (Lombardi & 
Terranova, 2007; Xiao et al., 1997, 1998). In other tissues, such as human fetal tracheal cells, 
cis PUFA and MUFA (e.g., arachidonic acid, linoleic acid, and oleic acid) but not SFA (e.g., 
stearic acid, palmitic acid, and myristic acid) modulate Cl- channel activity by interrupting 
the open channel current (Hwang et al., 1990). In smooth muscle cells, arachidonic acid, 
oleic acid, myristic acid, and linoleic acid but not myristoleic acid, caprylic acid, or palmitic 
acid activate K+ currents (Ordway et al., 1989; Robertson & Steinberg, 1990), also producing 
hyperpolarization. 
The motor cortex of the human brain contains primarily long-chain fatty acids, such as 
arachidonic acid (C20:4n-6) and DHA (C22:6n-3). Other shorter-chain fatty acids are more 
likely to be involved in vascular blood flow, and eicosanoid activity involved in responses to 
injury. In animals, through alternative processes of desaturation and elongation, arachidonic 
acid may be formed from linoleic acid (18:2n-6), and DHA may be formed from -linolenic 
acid (18:3n-3) but in a relatively inefficient manner because of the characteristics of being 
rate limited and very slow. Therefore, its ingestion in the diet seems to be crucial. Double-
blind, controlled studies are needed before reaching conclusions about the properties of 
PUFA as cardiac protectors. 
Intriguing results have been found regarding the actions of fatty acids in nervous tissue. 
Fatty acids regulate ion channels (Ordway et al., 1991) and can be delivered to the cells from 
extracellular sources, such as albumin and lipoproteins (Ordway et al., 1991). Fatty acids can 
enter the brain and exert their effects on neurons when administered systemically (Lauritzen 
et al., 2000). PUFA easily cross the blood-brain barrier and accumulate in neuronal 
membranes (Robinson & Rapoport, 1986). Arachidonic acid and other fatty acids regulate 
ion channels themselves through direct action or indirectly through their metabolites 
(Ordway et al., 1991). Likewise, at least one cis MUFA (oleic acid), one n-6 PUFA 
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(arachidonic acid), and one n-3 PUFA (DHA) increase the binding of [3H]diazepam to the 
benzodiazepine/-aminobutyric acid (GABA) receptor (Nielsen et al., 1988). Long-term 
ethanol or diazepam administration increases the proportions of plasma SFA and MUFA 
and decreases PUFA (Ristic et al., 1995). Therefore, some anxiolytic action may be expected. 
The inhibition of GABA neurotransmission by arachidonic acid or its peroxidized 
metabolites contributes to the pathogenesis of ischemia-perfusion neuronal injury because 
the accumulation of these n-3 PUFA (but not SFA) inhibits GABA-mediated neuronal 
inhibition, leading to increased neuronal excitability (Schwartz & Yu, 1992). This may be 
related to the observation that barbiturates produce a Ca2+-dependent decrease in Cl- flux 
through the GABAA receptor, which is reduced by phospholipase A2 (Schwartz et al., 1988), 
leading to the increased formation of oxygen free radicals and consequently apoptosis. 
Interestingly, in the hippocampus, arachidonic acid helps maintain membrane fluidity 
(Fukaya et al., 2007) and enhances synaptic transmission (Williams et al., 1989). PUFA but 
not MUFA or SFA inactivate Na+ currents, reducing neuronal firing and increasing their 
refractory period in CA1 neurons (Vreugdenhil et al., 1996). 
In neuroblastoma/glioma hybrid cell culture studies, PUFA (e.g., linoleic acid, linolenic 
acid, and arachidonic acid) decrease Na+ action potentials. One trans MUFA (i.e., oleic acid) 
does not produce such changes, and one SFA (i.e., palmitic acid) and one trans MUFA (i.e., 
elaidic acid) increase the frequency and amplitude of action potentials without influencing 
resting membrane potentials, Ca2+ action potentials, or membrane capacitance (Love et al., 
1985). 
Arachidonic acid also appears to modulate the activity of cytosolic protein kinase C by 
selective induction of phosphorylation, modulating transmembrane signaling (Khan et al., 
1991). The fluidity of the acyl chains of fatty acids present in the bulk of membrane 
phospholipids modulates enzymatic activity (Harris, 1985). 
In summary, n-3 PUFA modify some membrane functions, such as ion channel modulation, 
by increasing membrane fluidity (Simopoulos, 1999). The ion channel modulation exerted 
by fatty acids is very similar to that produced by local anesthetics, such lidocaine (Bean et 
al., 1983), and some anticonvulsant drugs, such as phenytoin (Rogawski & Porter, 1990; 
Schwartz & Grigat, 1989). The activation of several neurotransmitter receptors, such as 
dopamine D2, 5-hydroxytryptamine-3, and opioids, alters the membrane flux of K+ 
(Drukarch et al., 1989; Miyake et al., 1989). Some of the known effects of DHA include 
changes in membrane fluidity and stability (Litman et al., 2001), changes in dopaminergic 
and serotonergic transmission (Chalon et al., 2001; Zimmer et al., 2000, 2002), and the 
regulation of membrane-bound enzymes and cellular signal transduction (McNamara et al., 
2006; Vaidyanathan et al., 1994). 
2.8 Clinical aspects 
The role of essential fatty acids in mammals was long been unknown, but more similarities 
than discrepancies appear to exist between the general actions of SFA, MUFA, and PUFA on 
diet pleasantness, visual appearance, smell, taste, aftertaste, and palatability, subjective 
hunger ratings, and energy intake in healthy males (Strik et al., 2010). Differences can be 
found with regard to undesirable effects. With regard to cholesterolemia, no differences 
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were found between diets rich in MUFA and PUFA, but a SFA-rich diet produced the 
highest cholesterol concentrations (Trautwein et al., 1999). Decades ago, fatty acids were 
perceived as precursors for the biosynthesis of other substances (e.g., those related to 
inflammatory processes) and other fatty acids (Friesen & Innis, 2006) that are components of 
the cell membrane (Carrié et al., 2000) may participate in many functional processes (Kidd, 
2007). 
2.9 Development 
Docosahexaenoic acid is the main n-3 PUFA found in the phospholipid fraction of the brain 
and has been implicated in the prenatal and postnatal development of the retina and brain 
(Hamazaki et al., 1996; McCann & Ames, 2005; SanGiovanni et al., 2000). Deficiencies in 
DHA during development are related to deficits in the structure of the retina, impairing 
visual acuity and cognitive function (Crawford, 1993; Neuringer et al., 1986; Reisbick et al., 
1997). 
During pregnancy, dietary trans fatty acids (e.g., elaidic acid) produce deleterious effects on 
health. The most abundant long-chain fatty acids in breast milk are DHA and arachidonic 
acid. Supplementation with marine oil products does not produce adverse effects and 
improves sensorial function and other cognitive functions after birth (Brenna & Lapillonne, 
2009). Supplementation with DHA in infants that are less than 1 year old improves seeking 
behavior that later it is related to increased exploratory activity and less distractibility 
(Colombo et al., 2004). A DNA microarray study of the brain in rats subjected to different 
diets that contained different amounts of n-3 PUFA found some deficiencies in the 
expression of several genes, which became up- or downregulated and were related to the 
expression of cytochrome c and tumor necrosis factor (Kitajka et al., 2004). Maternal dietary 
SFA may produce persistent alterations in Na+,K+-ATPase function in the offspring, which 
could increase the risk of adulthood disease (Armitage et al., 2008). 
2.10 Cognitive impairment 
Decreased plasma levels of n-6 PUFA have been associated with physical rather than 
cognitive or behavioral ailments (Richardson, 2006). Deficiencies in DHA and 
eicosapentaenoic acid are involved in behavioral problems, such as attention deficit 
hyperactivity disorder, autism, dyspraxia, dyslexia, and aggression (Richardson, 2006; 
Stevens et al., 1996), and affective disorders, such as major depressive disorder, bipolar 
disorder, schizophrenia, and personality disorder. Evidence of altered PUFA status in 
mental illness, however, is weak. Reports of symptom improvement after PUFA 
consumption included patients with previous generalized dietary deficiencies of fatty acids 
(Liperoti et al., 2009; Milte et al., 2009) or other deleterious lifestyle habits (Suominen-
Taipale et al., 2010), thus contaminating the interpretation of the data. n-3 PUFA 
supplementation appears to be effective only in depressive or Alzheimer’s carriers of non-
apolipoprotein E epsilon4 (Solfrizzi et al., 2010). In animal models of Alzheimer’s disease, 
SFA and n-3 PUFA, including arachidonic acid, produced higher secretion of both A┚-40 
and -42 peptides compared with long-chain downstream omega-3 and MUFA. Lower levels 
of A┚ and amyloid plaques in the brain were observed when the subjects were fed a low-fat 
diet enriched with DHA (Amtul et al., 2011). 
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Some promising reports of the beneficial effects of n-3 PUFA on Alzheimer’s disease and 
Huntington’s disease showed that fatty acids appear to be devoid of any effect on cognition, 
aggression, hostility, and social behavior (Crawford et al., 2009). 
2.11 Depression 
Reports of the effects of fatty acids on depression have been controversial. For example, in 
an open-label study, juvenile bipolar disorder patients received supplementary 
eicosapentaenoic acid and DHA in their diet and exhibited a reduction in their clinical 
symptoms (Clayton et al., 2009). However, diets enriched with DHA failed to prevent 
postpartum depression in a randomized controlled trial (Makrides et al., 2010). 
However, some intriguing results have been found. Membrane viscosity plays a role in the 
molecular bases of depression and other disorders and mediates the pharmacology of 
serotonin. Depression has been associated with low lipid raft viscosity (Cocchi et al., 2010a). 
The hydroxytrytophan transporter responsible for serotonin reuptake may be the functional 
locus for depression (Rosen, 2009), and an inverse relationship has been found between 
arachidonic acid content in neural tissue and the accessibility of serotonin to its receptors. 
However, an increase in arachidonic acid in brain tissue reduced membrane viscosity (i.e., 
increased fluidity; Cocchi et al., 2010b), reducing the accessibility of serotonin to its 
receptors (Heron et al., 1980). The brains of Flinders Sensitive rats, an animal model of 
depression, contain high concentrations of arachidonic acid (Green et al., 2005). 
2.12 Calming effects of maternal biological fluids 
Some odors can elicit a sense of family and home safety in adult mammals. Schapiro and 
Salas (1970) demonstrated that exposure to maternal odors in rat pups before weaning 
reduced the movements of pups. Oswalt and Meier (1975) found that infant rats reduce their 
emission of ultrasonic vocalizations when exposed to maternal odors. Therefore, maternal 
litter or home odors produce signs of calm. In contrast, kittens, pups, and human babies 
exhibit increased agitation and vocalizations when placed in an unfamiliar environment, but 
when they return to their nest or close proximity to their mother, both familiar odors, they 
calm down (Christensson et al., 1995; Michelsson et al., 1996; Schaal, 1988). The application 
of amniotic fluid odor to the nose significantly reduced crying in human babies when they 
were separated from their mothers (Varendi et al., 1998). Sullivan and Toubas (1998) 
suggested that maternal odors could be used to calm and reduce crying in babies. These 
fluids may be used to promote the acceptance of nipple feeding (Sullivan & Toubas, 1998) 
because breast milk odors (Rattaz et al., 2005) and milk odor (Nishitani et al., 2009) produce 
signs of calm. Olfactory exposure to maternal biological fluids (i.e., amniotic fluid, 
colostrum, and breast milk) appears to promote breastfeeding (Winberg & Porter, 1998).  
Any odorant molecule requires a binding carrier protein with high affinity for membrane 
olfactory receptor neurons (Pelosi, 2001). Guiraudie-Capraz et al. (2005) used gas 
chromatography-mass spectrometry (GC-MS) to identify seven fatty acids (i.e., linoleic acid, 
palmitic acid, lauric acid, capric acid, myristic acid, palmitoleic acid, and oleic acids) in 
breast milk, colostrum, and amniotic fluid in pigs. Three carrier proteins were found not 
only in amniotic fluid, colostrum, and milk, but also in nasal mucosa and the vomeronasal 
organ, which seemingly mediate the fatty acid-induced initiation of perception (Guiraudie-
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Capraz et al., 2003; Tegoni et al., 2000) with different affinities (Guiraudie-Capraz et al., 
2003). Therefore, these proteins participate in the detection of chemical and biochemical 
signals, at least in pigs (Guiraudie-Capraz et al., 2005). Notably, these proteins have also 
been found in human amniotic fluid (Liberatori et al., 1997) and colostrum (Murakami et al., 
1998), suggesting the stimulation of olfactory receptors very early in life, even during 
intrauterine life. 
2.13 Fatty acids and anxiety 
Few studies have compared the effects of n-3 and n-6 fatty acids on behavior. Although 
better results have been found in animals that received n-3 fatty acids than n-6 fatty acids 
(Wainwright, 1992), the absence of control groups prevents the acceptance of the results. 
Another study sought to find a relationship between essential fatty acids and behavior. 
Nakashima et al. (1993) used the elevated plus maze to assess anxiolytic-like behavior in 
rodents. In this study, linoleic acid produced a trend toward anxiolysis compared with -
linolenic acid, but this study also lacked a control group. 
In humans, Mamalakis et al. (1998) did not find any relationship between linoleic acid and 
myristic acid and anxiety measured with the Spielberg scale or trait anxiety measured and 
Zung scales. However, they detected a positive relationship between trait anxiety scores and 
the linoleic acid + ┙-linolenic acid / DHA + arachidonic acid ratio (Mills et al., 1994). 
However, a mixture of PUFA may reduce anxiety scores, reflected by increased appetite, 
increased sense of humor, increased strength, decreased fatigue, increased academic 
performance, decreased lack of sleep, and decreased plasma cortisol (Yehuda et al., 2005). 
Pageat (2001) patented a product whose active ingredient is a mixture of fatty acids that has 
been used to decrease stress, anxiety, and aggression in mammals, such as pigs, dogs, cats, 
and even children, and reduce anxiety signs when the animals are separated from their 
mother or in an unfamiliar place. The same formulation was tested by McGlone and 
Anderson (2002) on weight gain, feeding efficiency, and agonistic behavior in piglets. 
We recently used GC-MS to demonstrate that human amniotic fluid, colostrum, and 
maternal milk consistently contain eight fatty acids (Mendoza-López et al., 2010). Both 
human amniotic fluid and an artificial mixture of the same proportion of fatty acids 
produced anxiolytic effects comparable to diazepam in Wistar rats subjected to validated 
tests that measure anxiety, including the defensive burying test and elevated plus maze. We 
concluded that amniotic fluid and its fatty acids have anxiolytic effects (Contreras et al., 
2011). 
2.14 Fatty acids as feeding cues 
Newborns are attracted to odors that come from their mother's breast (Porter & Winberg, 
1999), milk, colostrum (Nowak et al., 2000), and amniotic fluid (Porter & Winberg, 1999; 
Schaal et al., 1998). This behavior could be related to the fact that during the last trimester, 
the odorants in amniotic fluid are in close contact with nasal chemoreceptors. Newborn 
infants may retain an olfactory memory of these odors and later respond to these signals 
during the early postnatal period (Hepper, 1995). 
Amniotic fluid is a complex mixture of fetal and maternal fluid (Lev & Orlic, 1972). Its 
composition varies according to gestational age and the evolution of maternal-fetal 
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exchange. During early pregnancy, amniotic fluid is predominantly an ultrafiltrate of 
maternal serum. During late pregnancy, fetal urine is the main constituent of amniotic fluid 
(Loughhead et al., 2006). 
Newborns oriented longer time to the odor of their own amniotic fluid compared with an 
unscented control (Schaal et al., 1995; Varendi et al., 1996). Recently, Contreras et al. (2011) 
analyzed the amniotic fluid, colostrum, and breast milk of 15 volunteer women. Eight fatty 
acids were consistently found in measurable amounts in the three biological fluids, 
including lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, 
elaidic acid, and linoleic acid. The total amounts of fatty acids were different in each fluid, 
with the lowest amount found in amniotic fluid, followed by colostrum and milk. These 
results suggest that similar to other mammalian species (Guiraudie-Capraz et al., 2005; 
Pageat, 2001), some fatty acids present in biological fluids could serve as sensory cues of 
maternal and child identification. Additionally, newborns younger than 24 h preferentially 
orientated toward their own amniotic fluid and an artificial mixture of similar fatty acids 
(Díaz-Marte et al., 2010). This suggests that the first recognition of odors occurs during 
intrauterine life. Some of the fatty acids present in amniotic fluid could be a source of 
prenatal sensory stimulation, and colostrum odor is a bridge between amniotic fluid and 
milk (Contreras et al., 2011), thus leading to feeding behavior. Therefore, fatty acids could 
act as feeding cues, leading to appetitive behavior. 
3. Conclusions 
1. The functions of fatty acids as energy sources and their structural role in cellular 
membranes and as precursors of inflammatory processes are well known.  
2. Fatty acids may modify the fluidity of the lipid membrane of cardiac and neuronal cells, 
impinging on ion channel permeability and decreasing cellular excitability. These 
conformational changes in the membrane may also modulate some neurotransmitter 
functions. 
3. Decreased excitability produced by long-chain PUFA is related to some beneficial 
effects on cardiac function. 
4. Similar actions on cardiac cell membranes appear to occur in neurons, in addition to 
neurotransmitter modulation. Some clinical studies of the therapeutic effects of fatty 
acids on neurological and psychiatric diseases have been conducted, but most of these 
studies need to be replicated using double-blind controlled designs before definitive 
conclusions can be made. 
5. Fatty acids are components of amniotic fluid, colostrum, and milk and produce some 
anxiolytic effects. 
6. The sensorial process of odor recognition related to fatty acids has been identified. 
7. Fatty acids in maternal-fetal fluids appear to act as feeding cues that guide newborns to 
the maternal breast. 
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